AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

BİOTREND ÇEVRE VE ENERJİ YATIRIMLARI A.Ş.

Pre-Annual General Meeting Information Apr 29, 2022

5897_rns_2022-04-29_f929f37f-1f62-426b-a06e-756e928ba3ed.pdf

Pre-Annual General Meeting Information

Open in Viewer

Opens in native device viewer

BİOTREND ÇEVRE VE ENERJİ YATIRIMLARI ANONİM ŞİRKETİ INVITATION TO THE ORDINARY GENERAL ASSEMBLY MEETING FOR THE YEAR 2021 BY THE BOARD OF DIRECTORS

To discuss and resolve the following agenda, the Ordinary General Assembly will be convened on Friday April 29, 2022, at 13:00 p.m. at Kavacık Mahallesi, Ertürk Sokak, No: 3/1, İç Kapı No:1, Beykoz, Istanbul.

The Board of Directors Annual Report for the 2021 accounting period, Corporate Governance Principles Compliance Report, Corporate Governance Information Form, Financial Statements, Independent Audit Report, Proposal on Dividend Distribution, General Assembly Information Document, Proxy Form and other relevant documents pertaining to our Company that must be submitted to the inspection of the shareholders prior to the general assembly as per the legislation will be available for review by our Shareholders within the legal three-week period prior to the meeting, excluding the meeting and announcement days at the Company address in Kavacık Mahallesi, Ertürk Sokak, No:3/1, İç Kapı No:1, Beykoz, Istanbul, on our company's website www.biotrendenerji.com.tr and the Electronic General Meeting System ("e-GKS") system.

Shareholders who will not attend the meeting in person, to be able to use their voting rights through a proxy, must submit their notarized proxy form to our company in accordance with the sample attached and the regulations of the Communiqué on Voting by Proxy and Proxy Solicitation (II-30.1) of the Capital Markets Board. You can obtain a proxy form from our company headquarters or website www.biotrendenerji.com.tr A proxy appointed via the Electronic General Meeting System ("e-GKS") can attend the General Meeting both in person or via the e-GKS without submitting any other proxy document. A proxy who wishes to attend the meeting in person, regardless of whether they have been appointed by a notarized proxy form or authorized via the e-GKS, must present an ID card to be able participate in the meeting.

To electronically attend the Ordinary General Assembly, our shareholders or their representatives must fulfill the relevant obligations as per the "Communiqué on the Electronic General Assemblies of Joint Stock Companies" published in Official Gazette No. 28395 on August 28, 2012, and the "Communiqué on the Use of Electronic General Assembly System to be Implemented at the General Assemblies of Joint Stock Companies" published in Official Gazette No. 28396 on August 29, 2012. For more information on the regulations, please contact the MKK or visit www.mkk.com.tr

As per the Turkish Commercial Code and the Capital Markets Law, shareholders who want to participate in the Ordinary General Assembly are not required to deposit their shares in an institution. To attend to the General Assembly, our shareholders must fulfill the procedures publicly disclosed by the MKK. Only the shareholders whose names are in the list of attendees, which is based on the "list of shareholders" provided by the MKK, can attend the General Assembly. The list of attendees will be used to verify the shareholders or proxies coming to the conference hall to participate in the Ordinary General Assembly.

Respectfully submitted to our esteemed shareholders.

BİOTREND ÇEVRE VE ENERJİ YATIRIMLARI ANONİM ŞİRKETİ BOARD OF DIRECTORS

AGENDA OF THE ORDINARY GENERAL ASSEMBLY MEETING FOR THE YEAR 2021 TO BE HELD ON 29.04.2022 AT 13.00 PM

  • 1. The opening and election of the Chairman of the Meeting and delegating power to the Chairman of the Meeting to sign the meeting
  • 2. Reading, discussion and approval of the 2021 Annual Report of the Board of Directors
  • 3. Reading, discussion and approval of the 2021 Independent Auditor's Report prepared by the Independent Audit Firm
  • 4. Reading, discussion and approval of the 2021 Financial Statements
  • 5. Discussion on discharging the Board Members individually from liability regarding the operations and transactions of the company for the fiscal year 2021
  • 6. Reading, discussion and resolution of the Board of Directors' proposal on the profits and losses for the 2021 period
  • 7. Informing the General Assembly about the related party transactions in 2021
  • 8. Submitting for approval by the General Assembly the "Related Party Transactions Policy" prepared by the Board of Directors in compliance with the Communiqué II-17.1 on Corporate Governance of the Capital Markets Board and established following the decision numbered 2021/46, dated August 31, 2021 of the Board of Directors
  • 9. Informing the General Assembly concerning the changes made by the Board decision dated August 27, 2021, to the "Information Policy" which had been prepared by the Board in compliance with the Communiqué II-17.1 on Corporate Governance by the Capital Markets Board and approved by the Extraordinary General Assembly on February 25, 2021
  • 10. Informing and consulting the General Assembly concerning the changes made by the Board decision dated August 27, 2021, to the "Remuneration Policy" prepared by the Board in compliance with the Communiqué II-17.1 on Corporate Governance by the Capital Markets Board and approved by the Extraordinary General Assembly on February 25, 2021
  • 11. Submitting for approval by the General Assembly the changes made by the Board decision dated 05.04.2022 to the "Donations and Aid Policy" which had been prepared by the Board in compliance with the Communiqué II-17.1 on Corporate Governance by the Capital Markets Board and approved by the Extraordinary General Assembly on February 25, 2021
  • 12. Providing information to the shareholders on the application made by the Board of Directors with the report prepared by the Corporate Governance Committee about the 3 (three) Independent Board Members currently serving to the Capital Markets Board and the opinion of the Capital Markets Board in compliance with the Capital Markets Board's

Announcement dated 13.01.2022 and numbered 2022/2, our Company's inclusion in the 1st Group Companies since 2022

  • 13. Providing information to the shareholders on the "Remuneration Policy" and remunerations paid to the Board members and executives as per the Corporate Governance Principles
  • 14. Determining the attendance fees to be paid to the Board Members during their term of office
  • 15. Submission of the independent audit firm selected for the fiscal year 2022 by the Board of Directors for the approval of the General Assembly, upon recommendation by the Audit Committee
  • 16. Providing information to the General Assembly, pursuant to Article 1.3.6 of the Corporate Governance Communiqué No. II-17.1 issued by the Capital Markets Board
  • 17. Informing the General Assembly about the guarantees, securities and liens issued in favor of third parties in 2021, in accordance with the Capital Markets Board regulations
  • 18. Informing the General Assembly about the donations and aid granted to foundations and associations in 2021, and determination of an upper limit for donations in 2022, as per the Capital Markets Board regulations
  • 19. Authorizing the Members of the Board of Directors to engage in activities set forth in Articles 395 and 396 of the Turkish Commercial Code, and informing the General Assembly about the relevant activities done in fiscal year 2021, pursuant to the Corporate Governance Principles

20. Wishes and closure

POWER OF ATTORNEY

BİOTREND ÇEVRE VE ENERJİ YATIRIMLARI ANONİM ŞİRKETİ

I hereby appoint -------------------------------------------------------- introduced as detailed below as my proxy authorized to represent me, to vote, to make proposals and to sign the required papers in line with the views I express below at the Ordinary General Assembly of Biotrend Çevre ve Enerji Yatırımları A.Ş. that will convene on April 29, 2022, Friday at 13:00 pm at the address of Kavacık Mahallesi Ertürk Sokak No:3/1 İç Kapı No:1 Beykoz İstanbul

The Attorney's (*); Name Surname / Trade Name : TR ID Number/ Tax ID Number, Trade Register and Number and MERSİS Number : (*) Foreign shareholders should submit the equivalent information mentioned above. .

A) Scope Of Representatıon

The scope of representative power should be defined after choosing one of the options (a), (b) or (c) in the following sections 1 and 2.

1. About the agenda items of General Assembly;

  • a. The attorney is authorized to vote according to his/her opinion.
  • b. The attorney is authorized to vote on proposals of the attorney partnership management.
  • c. The attorney is authorized to vote in accordance with the following instructions stated in the table.

Instructions :

In the event that the shareholder chooses the (c) option, the shareholder should mark "Accept" or "Reject" box and if the shareholder marks the "Reject" box, then he/she should write the dissenting opinion to be noted down in the minutes of the general assembly. .

Agenda Items Accept Reject Dissenting
Opinion
1. The opening and election of the Chairman of the Meeting and delegating
power to the Chairman of the Meeting to sign the meeting
2.
Reading, discussion and approval of the 2021 Annual Report of the Board
of Directors
3.
Reading, discussion and approval of the 2021 Independent Auditor's
Report prepared by the Independent Audit Firm
4. Reading, discussion and approval of the 2021 Financial Statements
5.
Discussion on discharging the Board Members individually from liability
regarding the operations and transactions of the company for the fiscal year
2021
6.
Reading, discussion and resolution of the Board of Directors' proposal on
the profits and losses for the 2021 period
7. Informing the General Assembly about the related party transactions in
2021,
8. Submitting for approval by the General Assembly the "Related Party
Transactions Policy" prepared by the Board of Directors in compliance with the
Communiqué II-17.1 on Corporate Governance of the Capital Markets Board
and established following the decision numbered 2021/46, dated August 31,
2021 of the Board of Directors
9.
Informing the General Assembly concerning the changes made by the
Board decision dated August 27, 2021, to the "Information Policy" which had
been prepared by the Board in compliance with the Communiqué II-17.1 on
Corporate Governance by the Capital Markets Board and approved by the
Extraordinary General Assembly on February 25, 2021
10.
Informing and consulting the General Assembly concerning the changes
made by the Board decision dated August 27, 2021, to the "Remuneration
Policy" prepared by the Board in compliance with the Communiqué II-17.1 on
Corporate Governance by the Capital Markets Board and approved by the
Extraordinary General Assembly on February 25, 2021
11.
Submitting for approval by the General Assembly the changes made by
the Board decision dated 05.04.2022 to the "Donations and Aid Policy" which
had been prepared by the Board in compliance with the Communiqué II-17.1
on Corporate Governance by the Capital Markets Board and approved by the
Extraordinary General Assembly on February 25, 2021
12.
Providing information to the shareholders on the application made by
the Board of Directors with the report prepared by the Corporate Governance
Committee about the 3 (three) Independent Board Members currently serving
to the Capital Markets Board and the opinion of the Capital Markets Board in
compliance with the Capital Markets Board's Announcement dated 13.01.2022
and numbered 2022/2, our Company's inclusion in the 1st Group Companies
since 2022
13. Providing information to the shareholders on the "Remuneration Policy"
and remunerations paid to the Board members and executives as per the
Corporate Governance Principles
14.
Determining the attendance fees to be paid to the Board Members during
their term of office
15. Submission of the independent audit firm selected for the fiscal year 2022
by the Board of Directors for the approval of the General Assembly, upon
recommendation by the Audit Committee
16. Providing information to the General Assembly, pursuant to Article 1.3.6
of the Corporate Governance Communiqué No. II-17.1 issued by the Capital
Markets Board
17. Informing the General Assembly about the guarantees, securities and
liens issued in favor of third parties in 2021, in accordance with the Capital
Markets Board regulations,
18. Informing the General Assembly about the donations and aid granted to
foundations and associations in 2021, and determination of an upper limit for
donations in 2022, as per the Capital Markets Board regulations,
19. Authorizing the Members of the Board of Directors to engage in activities
set forth in Articles 395 and 396 of the Turkish Commercial Code, and informing
the General Assembly about the relevant activities done in fiscal year 2021,
pursuant to the Corporate Governance Principles,
20. Wishes and closure.

2. Special instruction related to other issues that may come up during General Assembly meeting and rights of minority :

a) The attorney is authorized to vote according to his/her opinion.

b) The attorney is not authorized to vote on these matters.

c) The attorney is authorized to vote for the items in accordance with the special instruction.

Special Instruction; The special instructions (if there is any) to be given by the shareholder to the attorney are stated herein.

B) The shareholder specifies the shares to be represented by the attorney by choosing one of thefollowing.

1. I hereby confirm that the attorney represents the shares specified in detail as below

  • a) Order and Serial:*
  • b) Number/Group:**
  • c) Amount-Nominal Value:

ç) Privilige on Vote or not:

d) Bearer- Registered:*

e) Ratio of the total shares/voting rights of the shareholder:

(*)Such information is not required for dematerialized shares.

(**)For dematerialized shares, information related to the group will be given instead of number.

2. I hereby confirm that the attorney represents all my shares on the list, prepared by MKK (Central Registry Agency) the day before the Meeting, concerning the shareholders who could attend the General Assembly Meeting.

SHAREHOLDER'S(*)

Name Surname OR Tittle :

TR ID Number/ Tax ID Number, Trade Register and Number and MERSİS Number :

Address :

Signiture :

(*)Foreign shareholders should submit the equivalent information mentioned above.

Talk to a Data Expert

Have a question? We'll get back to you promptly.